Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Argenx SE
  6. News
  7. Summary
    ARGX   NL0010832176

ARGENX SE

(ARGX)
  Report
Real-time Euronext Bruxelles  -  11:36 2022-06-24 am EDT
336.30 EUR   -1.09%
06/24Argenx Gets Positive CHMP Opinion for Generalized Myasthenia Gravis Drug
MT
06/24Argenx Gets EU Committee's Positive Opinion For Generalized Myasthenia Gravis Treatment
MT
06/24argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Decline in Thursday Trading

05/05/2022 | 11:49am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMARIN CORPORATION PLC -3.52% 1.92 Delayed Quote.-43.03%
ARGENX SE -1.09% 336.3 Real-time Quote.6.66%
AUTOLUS THERAPEUTICS PLC 2.80% 2.57 Delayed Quote.-50.48%
CREDIT SUISSE GROUP AG 5.15% 5.72 Delayed Quote.-35.53%
DBV TECHNOLOGIES -1.19% 4.476 Real-time Quote.46.32%
IDEX BIOMETRICS ASA -1.44% 1.167 Real-time Quote.-63.07%
IDEX CORPORATION 3.32% 185.56 Delayed Quote.-21.48%
LLOYDS BANKING GROUP PLC 2.61% 43.415 Delayed Quote.-9.17%
MATERIALISE NV 1.81% 14.61 Delayed Quote.-38.79%
MEREO BIOPHARMA GROUP PLC 8.51% 1.53 Delayed Quote.-4.38%
MIDATECH PHARMA PLC 0.00% 9.25 Delayed Quote.-49.32%
NATUZZI S.P.A. 3.08% 8.37 Delayed Quote.-47.46%
NATWEST GROUP PLC 1.60% 222.6 Delayed Quote.-1.37%
TC BIOPHARM (HOLDINGS) PLC 0.13% 0.3894 End-of-day quote.0.00%
VIA OPTRONICS AG 3.17% 2.6 Delayed Quote.-64.63%
WISEKEY INTERNATIONAL HOLDING AG 4.67% 0.28 Delayed Quote.-62.96%
All news about ARGENX SE
06/24Argenx Gets Positive CHMP Opinion for Generalized Myasthenia Gravis Drug
MT
06/24Argenx Gets EU Committee's Positive Opinion For Generalized Myasthenia Gravis Treatment
MT
06/24argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patie..
GL
06/24Argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patie..
AQ
06/17European ADRs Move Lower in Friday Trading
MT
06/15TRANSCRIPT : Argenx SE Presents at Goldman Sachs 43rd Annual Global Healthcare Conference,..
CI
06/07European ADRs Move Higher in Tuesday Trading
MT
06/03European ADRs Move Lower in Friday Trading
MT
06/01argenx to Present at Upcoming Investor Conferences
GL
06/01Argenx to Present at Upcoming Investor Conferences
AQ
More news
Analyst Recommendations on ARGENX SE
More recommendations
Financials
Sales 2022 171 M 181 M 181 M
Net income 2022 -937 M -988 M -988 M
Net cash 2022 1 439 M 1 518 M 1 518 M
P/E ratio 2022 -17,4x
Yield 2022 -
Capitalization 18 373 M 19 381 M 19 381 M
EV / Sales 2022 98,8x
EV / Sales 2023 35,8x
Nbr of Employees 650
Free-Float 100%
Chart ARGENX SE
Duration : Period :
argenx SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARGENX SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 336,30 €
Average target price 357,45 €
Spread / Average Target 6,29%
EPS Revisions
Managers and Directors
Tim van Hauwermeiren Chief Executive Officer
Karl Gubitz Chief Financial Officer
Peter K. M. Verhaeghe Non-Executive Chairman
Hans J. W. de Haard Chief Scientific Officer
Luc Truyen Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARGENX SE6.66%19 381
GILEAD SCIENCES, INC.-13.12%79 122
VERTEX PHARMACEUTICALS33.22%74 821
REGENERON PHARMACEUTICALS, INC.-3.01%65 993
WUXI APPTEC CO., LTD.-13.42%44 742
BIONTECH SE-48.01%32 574